Search

Search results

203 results found

Structural and immunological comparison of human thrombospondins isolated from platelets and from culture supernatants of endothelial cells and fibroblasts. Evidence for a thrombospondin polymorphism.

Clezardin, P, N R Hunter, J W Lawler, D A Pratt, J L McGregor, D S Pepper, and J Dawes. 1986. “Structural and Immunological Comparison of Human Thrombospondins Isolated from Platelets and from Culture Supernatants of Endothelial Cells and Fibroblasts. Evidence for a Thrombospondin Polymorphism.”. European Journal of Biochemistry 159 (3): 569-79.

Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer.

Matuszewska, Kathy, Lisa A Santry, Jacob P van Vloten, Amanda W K AuYeung, Pierre P Major, Jack Lawler, Sarah K Wootton, Byram W Bridle, and Jim Petrik. 2019. “Combining Vascular Normalization With an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer.”. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 25 (5): 1624-38.

Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer.

Russell, Samantha, Mark Duquette, Joyce Liu, Ronny Drapkin, Jack Lawler, and Jim Petrik. 2015. “Combined Therapy With Thrombospondin-1 Type I Repeats (3TSR) and Chemotherapy Induces Regression and Significantly Improves Survival in a Preclinical Model of Advanced Stage Epithelial Ovarian Cancer.”. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 29 (2): 576-88.